Image 2_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Table 5_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Table 2_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Table 7_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Table 1_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Image 7_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Table 6_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Table 3_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Image 6_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

Image 3_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). …”

a-d. Molecular profile of heat-treated purified A1AT. by Ilaria Ferrarotti (142893)

“…However, heating of A1AT for 45 min or longer, resulted in a remarkable decrease in the nephelometric signal relative to the native protein.…”

Zinc deficiency affects apoptosis, activity, and differentiation of hiPSC-CMs. by Xiaoyu Zhang (62901)

SENP5 knockdown antagonizes the effect of TPEN on apoptosis and induced abnormal differentiation of hiPSCs. by Xiaoyu Zhang (62901)

“…*<i>P</i> < 0.05 vs. control; ^#<i>P</i> < 0.05 vs. …”

Effect of precipitation frequency on litter decomposition of three annual species (<i>Setaria viridis, Artemisia sacrorum</i>, and <i>Chenopodium acuminatum</i>) in a semi-arid san... by Yongqing Luo (5233820)

“…Litter decomposition and the C and N dynamics were influenced by species, depth, and <i>PF</i>. Low <i>PF</i> significantly decreased litter decomposition (mass loss rates of 49.7, 49.1, and 41.2% for PF1, PF2, and PF3, respectively). …”

Categorization of NIAMS grants, funding, and US Global Burden of Disease DALY metrics (arranged in order of decreasing US DALY). by Chante Karimkhani (594512)

Partial Loss of Genomic Imprinting Reveals Important Roles for Kcnq1 and Peg10 Imprinted Domains in Placental Development by Erik Koppes (779493)

“…We conclude that the <i>Peg10</i> and <i>Kcnq1</i> ICRs are key regulators of mid-gestation placental function.…”

Individual hippocampal CA1 pyramidal cells differed in their responses to Zolpidem. by Tamara Berdyyeva (654876)

Effect of TRPV1 inhibition on myofibroblast development in culture. by Yuanquan Yang (465628)

“…<p>Seventy two hrs post-treatment images. <b>A</b>. Control. Note absence of stress fibers. …”

AMPK depletion is associated with decreased association of OGT with proteasome and increased 26S proteasome assembly and activity in AMPK-KO mice. by Jian Xu (31545)

Open data: Visual load does not decrease the auditory steady state response to 40-Hz amplitude-modulated tones by Stefan Wiens (3862558)

“…<div><div>Open data: Visual load does not decrease the auditory steady state response to 40-Hz amplitude-modulated tones</div></div><div><br></div><div><div>The main results files are saved separately:</div><div><br></div><div>- ASSR_study1.html: R output of the main analyses</div><div>- ASSR_study1_subset_subjects.html: R output of the main analyses</div><div>- ASSR_study2.html: R output of the main analyses</div></div><div><br></div><div><div>The studies were preregistered:</div><div>Study 1: https://doi.org/10.17605/OSF.IO/UYJVA</div><div>Study 2: https://doi.org/10.17605/OSF.IO/JVMFD</div></div><div><br></div><div><div><b>DATA & FILE OVERVIEW</b></div><div><br></div><div>File List:</div><div>The files contain the raw data, scripts, and results of main and supplementary analyses of two electroencephalography (EEG) studies (Study1, Study2). …”